Non-Hodgkin's Lymphoma
Showing NaN - NaN of 14
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
-
Duarte, California
- +12 more
Jun 17, 2022
Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))
Terminated
- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia
- hLL1-DOX (IMMU-115)
-
Newark, Delaware
- +5 more
Oct 6, 2021
Non-Hodgkin's Lymphoma Trial in United States (Y-90-Zevalin, Moxtezafin Gadolinium, Rituximab)
Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Russian Federation, United States (SB-743921)
Completed
- Non-Hodgkin's Lymphoma
- Hodgkin's Disease
-
Hackensack, New Jersey
- +7 more
Jan 9, 2020
Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)
Completed
- Non-Hodgkin's Lymphoma
-
Mobile, Alabama
- +120 more
Dec 20, 2019
Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)
Terminated
- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma
- Lenalidomide
- Placebo
-
San Diego, California
- +91 more
Nov 6, 2019
Non-Hodgkin's Lymphoma, Hodgkins Disease Trial in United States (Fludarabine, Busulfan, Anti-Thymocyte Globulin)
Completed
- Non-Hodgkin's Lymphoma
- Hodgkins Disease
- Fludarabine
- +2 more
-
Chicago, Illinois
- +5 more
Mar 4, 2019
Cancer, Chronic Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Hackensack, Durham, Salt Lake City (AMG 319)
Completed
- Cancer
- +13 more
- AMG 319
-
Hackensack, New Jersey
- +2 more
Feb 8, 2017
Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)
Completed
- Non-Hodgkin's Lymphoma
- obinutuzumab (RO5072759)
- rituximab
-
Los angeles, California
- +70 more
Aug 15, 2014
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013